Improvement in disinhibition and executive dysfunctions in patients with MDD receiving TMS may be associated with astrocyte protein S100B whereas GFAP may have a role in non-cognitive depressive symptom improvement
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2023-01-01
|
| Serija: | Brain Stimulation |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S1935861X23006502 |
| Oznake: |
Brez oznak, prvi označite!
|